Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | THRB | P10828 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21105245 | 0.82 | ALDH1A1 (0.41) | MEN1KMT2ANPC1RAB9ANPSR1 | |
| SCHEMBL19311819 | 0.82 | ALDH1A1 (0.41) | MEN1KMT2ANPC1RAB9ANPSR1 | |
| SCHEMBL26077682 | 0.82 | ALDH1A1 (0.41) | MEN1KMT2ANPC1RAB9ANPSR1 | |
| SCHEMBL21653369 | 0.82 | NPSR1 (0.43) | MEN1KMT2ANPC1RAB9ANPSR1 | |
| SCHEMBL20999115 | 0.78 | ALDH1A1 (0.37) | MEN1KMT2ANPC1RAB9ANPSR1 | |
| SCHEMBL22789489 | 0.78 | NPSR1 (0.36) | MEN1KMT2ANPSR1KDM4EALDH1A1 | |
| SCHEMBL20385070 | 0.78 | TRPM8 (0.49) | MEN1KMT2ANPSR1ALDH1A1MAPT | |
| SCHEMBL29320894 | 0.77 | ALDH1A1 (0.36) | MEN1KMT2ANPSR1KDM4EALDH1A1 | |
| SCHEMBL20684631 | 0.77 | ALDH1A1 (0.36) | MEN1KMT2ANPSR1KDM4EALDH1A1 | |
| SCHEMBL18809761 | 0.76 | ALDH1A1 (0.47) | MEN1KMT2ANPC1RAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180175295-A1 | SPIROFLUORENE DERIVATIVE, MATERIAL FOR LIGHT-EMITTING ELEMENT, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2018-06-21 | — | — | US | disclosed |
| US-9899602-B2 | Spirofluorene derivative, material for light-emitting element, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-02-20 | — | — | US | disclosed |
| US-20170125679-A1 | SPIROFLUORENE DERIVATIVE, MATERIAL FOR LIGHT-EMITTING ELEMENT, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2017-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170125679-A1 | SPIROFLUORENE DERIVATIVE, MATERIAL FOR LIGHT-EMITTING ELEMENT, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE | GRK1, PTGER2, PTGER1 | MEN1 2313/4885KMT2A 2751/4885NR3C2 43/4885 |
| US-20180175295-A1 | SPIROFLUORENE DERIVATIVE, MATERIAL FOR LIGHT-EMITTING ELEMENT, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE | GRK1, PTGER2, PTGER1 | MEN1 2313/4885KMT2A 2751/4885NR3C2 43/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.